Anti-thymocyte Globulin (Rabbit)

FDA Drug Profile — Thymoglobulin

Anti-thymocyte Globulin (Rabbit) is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Thymoglobulin. Available dosage form: injection, powder, lyophilized, for solution.

Drug details

Generic Name
Anti-thymocyte Globulin (Rabbit)
Brand Names
Thymoglobulin
Application Number
BLA103869
Sponsor
Genzyme Corporation
NDC Codes
1
Dosage Forms
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN

Indications and Usage

1 INDICATIONS AND USAGE THYMOGLOBULIN is indicated for the prophylaxis and treatment of acute rejection in adult and pediatric patients receiving a kidney transplant in conjunction with concomitant immunosuppression. THYMOGLOBULIN is an immunoglobulin G indicated for the prophylaxis and treatment of acute rejection in adult and pediatric patients receiving a kidney transplant in conjunction with concomitant immunosuppression. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.